AlloCyte Pharmaceuticals AG Company
AlloCyte Pharmaceuticals AG is a Swiss company established in 2011 that focuses on creating small molecule drugs to treat severe immune-mediated diseases. They target integrins, a potent drug target, using a unique pharmacological approach. The company's funding comes from private investors and public funds, including the Swiss Commission for Technology and Innovation.
